Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918791 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
For NSCLC patients treated with concurrent chemotherapy and IMRT A higher number of cisplatin administrations, non-Caucasian background and higher V50oes were associated with grade 3 AET. The median onset of AET grade 3 is 15Â days after the start of treatment, maximized at day 30, with a median duration of >80Â days.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Wilma Uyterlinde, Chun Chen, Margriet Kwint, Josien de Bois, Andrew Vincent, Jan-Jakob Sonke, Jose Belderbos, Michel van den Heuvel,